Effect of Remote Ischemic Conditioning on Cerebral Hemodynamics in Patients After Intravenous Thrombolysis (RICCH-IVT)

Sponsor
Yi Yang (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05598658
Collaborator
(none)
100
2
8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the effect of remote ischemic conditioning on cerebral hemodynamics in patients after intravenous thrombolysis

Condition or Disease Intervention/Treatment Phase
  • Procedure: Remote ischemic conditioning
  • Procedure: Sham remote ischemic conditioning
N/A

Detailed Description

In this study, cases of ischemic stroke who undergo intravenous thrombolysis within 4.5 hours from onset are included. The RIC group receive basic treatment and remote ischemic conditioning for 200mmHg at 6 and 18-24 hours after intravenous thrombolysis. The sham-RIC group receive basic treatment and remote ischemic conditioning for 60mmHg at 6 and 18-24 hours after intravenous thrombolysis. Both groups underwent cerebral hemodynamics after RIC and recorded the relevant indexes. The investigators aimed to determine the effect of remote ischemic conditioning on cerebral hemodynamics in patients after intravenous thrombolysis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Remote Ischemic Conditioning on Cerebral Hemodynamics in Patients After Intravenous Thrombolysis (RICCH-IVT)
Anticipated Study Start Date :
Nov 30, 2022
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: RIC group

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 200 mm Hg. RIC will be conducted at 6 and 18-24 hours after intravenous thrombolysis.

Procedure: Remote ischemic conditioning
Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 200 mm Hg.

Placebo Comparator: Sham-RIC group

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 60 mm Hg. RIC will be conducted at 6 and 18-24 hours after intravenous thrombolysis.

Procedure: Sham remote ischemic conditioning
Sham remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 60 mm Hg.

Outcome Measures

Primary Outcome Measures

  1. Cerebral autoregulation parameter [1-10 days]

    Cerebral autoregulation parameters derived from transfer function analysis. Continuous cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler. Spontaneous arterial blood pressure will be simultaneously recorded using a servo-controlled plethysmograph on the left or right middle finger with an appropriate finger cuff size. Transfer function analysis will be used to derive the autoregulatory parameter.

Secondary Outcome Measures

  1. Cerebral blood flow velocity [1-10 days]

    Cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. age ≥ 18 and < 80 years, both sexes;

  2. a clear clinical diagnosis of acute ischemic stroke and treatment with standard rt-PA (0.9 mg/kg) IVT within 4.5 h of stroke onset;

  3. pre-onset modified Rankin Scale (mRS) score ≤1;

  4. baseline National Institute of Health Stroke Scale (NIHSS) score ≥5 and ≤25;

  5. Glasgow Coma Scale score ≥8.

Exclusion Criteria:
  1. having received bridging therapy (IVT plus mechanical thrombectomy);

  2. previous history of atrial fibrillation or electrocardiographic evidence of atrial fibrillation;

  3. contraindications to RIC treatment or previous RIC treatment or similar treatment;

  4. pregnancy or breastfeeding;

  5. life expectancy of ≤3 months or inability to complete the study for other reasons;

  6. unwillingness to be followed up or poor treatment compliance or participation in other clinical studies;

  7. had insufficient bilateral temporal bone windows for insonation of the middle cerebral artery.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Yi Yang

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yi Yang, Associated Dean of First Hospital of Jilin University, The First Hospital of Jilin University
ClinicalTrials.gov Identifier:
NCT05598658
Other Study ID Numbers:
  • RICCH-IVT
First Posted:
Oct 28, 2022
Last Update Posted:
Dec 2, 2022
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yi Yang, Associated Dean of First Hospital of Jilin University, The First Hospital of Jilin University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 2, 2022